Search

Now showing items 1-10 of 19

Cytoskeletal re-arrangement in TGF-beta1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis

EHRHARDT, CARSTEN; DAVIES, ANTHONY; MEDINA MARTIN, CARLOS (2012)

In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric acid) conjugates with the model compound ibuprofen

EHRHARDT, CARSTEN (2010)

Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery

TAJBER, LIDIA; EHRHARDT, CARSTEN; PALUCH, KRZYSZTOF; HEALY, ANNE (2013)

The verapamil transporter in human alveolar epithelial cells (A549) does not interact with β2-receptor agonists

EHRHARDT, CARSTEN (2014)

Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery

EHRHARDT, CARSTEN (2008)

Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism

EHRHARDT, CARSTEN (2012)

The receptor for advanced glycation end-products (RAGE) and the lung

BUCKLEY, STEPHEN; EHRHARDT, CARSTEN (2010)

Stability of salmon calcitonin against trypsin, chymotrypsin and neutrophil elastase in human lung epithelial cells

EHRHARDT, CARSTEN; BAGINSKI, EVE LEONIE; BUCKLEY, STEPHEN (2010)

The particle has landed - characterizing the fate of inhaled pharmaceuticals

EHRHARDT, CARSTEN (2010)

Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells

SALOMON, JOHANNA; EHRHARDT, CARSTEN; BUCKLEY, STEPHEN (2012)

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Cytoskeletal re-arrangement in TGF-beta1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis

In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric acid) conjugates with the model compound ibuprofen

Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery

The verapamil transporter in human alveolar epithelial cells (A549) does not interact with β2-receptor agonists

Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery

Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism

The receptor for advanced glycation end-products (RAGE) and the lung

Stability of salmon calcitonin against trypsin, chymotrypsin and neutrophil elastase in human lung epithelial cells

The particle has landed - characterizing the fate of inhaled pharmaceuticals

Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Advanced Search

Cytoskeletal re-arrangement in TGF-beta1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis

In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric acid) conjugates with the model compound ibuprofen

Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery

The verapamil transporter in human alveolar epithelial cells (A549) does not interact with &#946;2-receptor agonists

Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery

Troglitazone attenuates TGF-&#946;1-induced EMT in alveolar epithelial cells via a PPAR&#947;-independent mechanism

The receptor for advanced glycation end-products (RAGE) and the lung

Stability of salmon calcitonin against trypsin, chymotrypsin and neutrophil elastase in human lung epithelial cells

The particle has landed - characterizing the fate of inhaled pharmaceuticals

Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells

The verapamil transporter in human alveolar epithelial cells (A549) does not interact with β2-receptor agonists

Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism